Brief: Trinity Biotech Announces Q3 2021 Results
15/12/2021 23:25
Dec 15 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH ANNOUNCES Q3 2021 RESULTS, THE ENTRY INTO
A
$81,250,000 LOAN FACILITY TO REFINANCE THE COMPANY’S
EXCHANGEABLE SENIOR NOTES AND AGREEMENTS TO REPURCHASE
OUTSTANDING EXCHANGEABLE SENIOR NOTES
* Q3 REVENUE $22 MILLION
* QTRLY DILUTED EARNINGS PER ADS 8.7 CENTS
Source text for Eikon: ID:nGNX4PY7FL
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM